>>0ç¶ã
ãã®ç 究ã§ã¯ãçŽè±ã®æœåºç©ãæ·»å ãããšãCOVID-19ææã®åå ãŠã£ã«ã¹ã§ããSARS-CoV-2ãšçãã«ãã¹ãŠã£ã«ã¹ïŒå (BHV-1) ã®çŽ°èãžã®ææãé²ãããšãæããã«ãããŠããŸãã
ããã«SARS-CoV-2ã«ãã£ãŠäœãããã¹ãã€ã¯ã¿ã³ãã¯è³ªãšBHV-1ã«ãã£ãŠäœãããã¿ã³ãã¯è³ª(Glycoprotein D)ããçŽè±æœåºç©ã®æã€ã¿ã³ãã¯å解äœçšã«ãã£ãŠå€æ§ããããšã蚌æãããŸããã
èè ãã¯ãããããã¿ã³ãã¯åè§£é µçŽ ãããã«ç 究ããããšã«ãã£ãŠæãŠã£ã«ã¹è¬ã®éçºã«ã€ãªããå¯èœæ§ãææããŠããŸãã
çŽè±ã®å¹çšã«ã€ããŠã¯ããã®ããã°ã§ã床ã ãäŒãæããŠããŸãããã€ãã«COVID-19ææ察çã«ããªãå¯èœæ§ãæããã«ãããããšã¯ãå®ã«åã°ããããšã§ãã
ãã®ç 究ã¬ããŒãã¯æµ·å€ã¡ãã£ã¢ã§ã¯å€§ããäŒããããŠããã®ã§ãããæ®å¿µãªããšã«æ¥æ¬ã®ã¡ãã£ã¢ã§ã¯ã»ãšãã©äŒããããŠããŸããã
çŽè±ã«ã¯ãé èŠæŽè¡å çã«ãã£ãŠçºèŠãããçŽè±ãããŒãŒãšåŒã°ããè¡æ 溶解äœçšãããé µçŽ ãå«ãŸããŸãã
COVID-19ææã¯è¡ç®¡çãèµ·ããææçã§ãã®ã§ãè¡æ 溶解äœçšãããããšã¯ææåŸã®å䜵ç察çã«ããªãå¯èœæ§ãååã«ãããŸãã
ããæè¿ã®é èŠå çã®ãç 究ã§ã¯ãçŽè±ã«å«ãŸããæåã«ã¯ããã现èã®å¢æ®ãæå¶ããåããæ害éå±ææ³ãä¿ãåããããããšãåºç€ç 究ã«ãŠç¢ºèªãããŠããŠããŸãã
æ±æžæ代ã®é ãããæµè¡ãç ãèµ·ãããšçŽè±ã®éèŠãé«ãŸãåŸåããã£ããšãããŸããæ¯èŒçå®äŸ¡ã§èª°ã§ãå ¥æå¯èœãªã¹ãŒããŒããŒãã§ããçŽè±ãææ察çãšããŠæŽ»çšããããã®ã§ãã
ãã®ç 究ã§ã¯ãçŽè±ã®æœåºç©ãæ·»å ãããšãCOVID-19ææã®åå ãŠã£ã«ã¹ã§ããSARS-CoV-2ãšçãã«ãã¹ãŠã£ã«ã¹ïŒå (BHV-1) ã®çŽ°èãžã®ææãé²ãããšãæããã«ãããŠããŸãã
ããã«SARS-CoV-2ã«ãã£ãŠäœãããã¹ãã€ã¯ã¿ã³ãã¯è³ªãšBHV-1ã«ãã£ãŠäœãããã¿ã³ãã¯è³ª(Glycoprotein D)ããçŽè±æœåºç©ã®æã€ã¿ã³ãã¯å解äœçšã«ãã£ãŠå€æ§ããããšã蚌æãããŸããã
èè ãã¯ãããããã¿ã³ãã¯åè§£é µçŽ ãããã«ç 究ããããšã«ãã£ãŠæãŠã£ã«ã¹è¬ã®éçºã«ã€ãªããå¯èœæ§ãææããŠããŸãã
çŽè±ã®å¹çšã«ã€ããŠã¯ããã®ããã°ã§ã床ã ãäŒãæããŠããŸãããã€ãã«COVID-19ææ察çã«ããªãå¯èœæ§ãæããã«ãããããšã¯ãå®ã«åã°ããããšã§ãã
ãã®ç 究ã¬ããŒãã¯æµ·å€ã¡ãã£ã¢ã§ã¯å€§ããäŒããããŠããã®ã§ãããæ®å¿µãªããšã«æ¥æ¬ã®ã¡ãã£ã¢ã§ã¯ã»ãšãã©äŒããããŠããŸããã
çŽè±ã«ã¯ãé èŠæŽè¡å çã«ãã£ãŠçºèŠãããçŽè±ãããŒãŒãšåŒã°ããè¡æ 溶解äœçšãããé µçŽ ãå«ãŸããŸãã
COVID-19ææã¯è¡ç®¡çãèµ·ããææçã§ãã®ã§ãè¡æ 溶解äœçšãããããšã¯ææåŸã®å䜵ç察çã«ããªãå¯èœæ§ãååã«ãããŸãã
ããæè¿ã®é èŠå çã®ãç 究ã§ã¯ãçŽè±ã«å«ãŸããæåã«ã¯ããã现èã®å¢æ®ãæå¶ããåããæ害éå±ææ³ãä¿ãåããããããšãåºç€ç 究ã«ãŠç¢ºèªãããŠããŠããŸãã
æ±æžæ代ã®é ãããæµè¡ãç ãèµ·ãããšçŽè±ã®éèŠãé«ãŸãåŸåããã£ããšãããŸããæ¯èŒçå®äŸ¡ã§èª°ã§ãå ¥æå¯èœãªã¹ãŒããŒããŒãã§ããçŽè±ãææ察çãšããŠæŽ»çšããããã®ã§ãã